Schonfeld Strategic Advisors’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98M | Sell |
176,281
-2,747,137
| -94% | -$30.9M | 0.01% | 918 |
|
|
2025
Q1 | $13.4M | Sell |
2,923,418
-865,961
| -23% | -$3.96M | 0.08% | 220 |
|
|
2024
Q4 | $21.4M | Buy |
3,789,379
+1,382,176
| +57% | +$7.8M | 0.12% | 124 |
|
|
2024
Q3 | $11.7M | Buy |
+2,407,203
| New | +$11.7M | 0.08% | 211 |
|
|
2023
Q1 | – | Sell |
-51,640
| Closed | -$999K | – | 2572 |
|
|
2022
Q4 | $999K | Buy |
51,640
+28,627
| +124% | +$554K | 0.01% | 1146 |
|
|
2022
Q3 | $790K | Sell |
23,013
-2,368
| -9% | -$81.3K | 0.01% | 1425 |
|
|
2022
Q2 | $388K | Buy |
+25,381
| New | +$388K | ﹤0.01% | 1434 |
|